ID: ALA4791313

Max Phase: Preclinical

Molecular Formula: C43H60O13

Molecular Weight: 784.94

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COC(COCCCCCCCCCCCc1ccc2ccc3cccc4ccc1c2c34)CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O

Standard InChI:  InChI=1S/C43H60O13/c1-51-30(25-53-42-40(50)38(48)41(33(23-45)55-42)56-43-39(49)37(47)36(46)32(22-44)54-43)24-52-21-10-8-6-4-2-3-5-7-9-12-26-15-16-29-18-17-27-13-11-14-28-19-20-31(26)35(29)34(27)28/h11,13-20,30,32-33,36-50H,2-10,12,21-25H2,1H3/t30?,32-,33-,36+,37+,38-,39-,40-,41-,42-,43+/m1/s1

Standard InChI Key:  ZZPGGRPSJJRUCR-SENORJDNSA-N

Associated Targets(Human)

MDA-MB-435 38290 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Small conductance calcium-activated potassium channel protein 3 139 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Small conductance calcium-activated potassium channel protein 3 210 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 784.94Molecular Weight (Monoisotopic): 784.4034AlogP: 3.31#Rotatable Bonds: 22
Polar Surface Area: 196.99Molecular Species: NEUTRALHBA: 13HBD: 7
#RO5 Violations: 3HBA (Lipinski): 13HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.94CX Basic pKa: CX LogP: 4.23CX LogD: 4.23
Aromatic Rings: 4Heavy Atoms: 56QED Weighted: 0.05Np Likeness Score: 1.02

References

1. Bauduin A,Papin M,Chantôme A,Couthon H,Deschamps L,Requejo-Isidro J,Vandier C,Jaffrès PA.  (2021)  Development of pyrene-based fluorescent ether lipid as inhibitor of SK3 ion channels.,  209  [PMID:33049604] [10.1016/j.ejmech.2020.112894]

Source